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Abstract: Background: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain
stimulation tool potentially modulating pathological brain activity. Its clinical effectiveness is ham-
pered by varying results and characterized by inter-individual variability in treatment responses.
RTMS individualization might constitute a useful strategy to overcome this variability. A precon-
dition for this approach would be that repeatedly applied protocols result in reliable effects. The
condition tinnitus provides the advantage of immediate behavioral consequences (tinnitus loudness
changes) after interventions and thus offers an excellent model to exemplify TMS personalization.
Objective: The aim was to investigate the test–retest reliability of short rTMS stimulations in modi-
fying tinnitus loudness and oscillatory brain activity as well as to examine the feasibility of rTMS
individualization in tinnitus. Methods: Three short verum (1, 10, 20 Hz; 200 pulses) and one sham
(0.1 Hz; 20 pulses) rTMS protocol were administered on two different days in 22 tinnitus patients.
Before and after each protocol, oscillatory brain activity was recorded with electroencephalography
(EEG), together with behavioral tinnitus loudness ratings. RTMS individualization was executed on
the basis of behavioral and electrophysiological responses. Stimulation responders were identified
via consistent sham-superior increases in tinnitus loudness (behavioral responders) and alpha power
increases or gamma power decreases (alpha responders/gamma responders) in accordance with
the prevalent neurophysiological models for tinnitus. Results: It was feasible to identify individ-
ualized rTMS protocols featuring reliable tinnitus loudness changes (55% behavioral responder),
alpha increases (91% alpha responder) and gamma decreases (100% gamma responder), respectively.
Alpha responses primary occurred over parieto-occipital areas, whereas gamma responses mainly
appeared over frontal regions. On the contrary, test–retest correlation analyses per protocol at a
group level were not significant neither for behavioral nor for electrophysiological effects. No asso-
ciations between behavioral and EEG responses were found. Conclusion: RTMS individualization
via behavioral and electrophysiological data in tinnitus can be considered as a feasible approach to
overcome low reliability at the group level. The present results open the discussion favoring per-
sonalization utilizing neurophysiological markers rather than behavioral responses. These insights
are not only useful for the rTMS treatment of tinnitus but also for neuromodulation interventions in
other pathologies, as our results suggest that the individualization of stimulation protocols is feasible
despite absent group-level reliability.
Keywords: repetitive transcranial magnetic stimulation; tinnitus; neuro-navigation; electroen-
cephalography; reliability; rTMS personalization
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1. Introduction
With a prevalence of about 10% of the population, tinnitus is a rather common con-
dition. It is characterized by the perception of ringing or hissing in the absence of a
corresponding external stimulus. The majority of tinnitus cases are caused by cochlear
damage leading to hearing loss [1–3], whereby the absence of auditory input from the pe-
riphery provokes maladaptive neural changes, which ultimately manifest in hyperactivity
of auditory and non-auditory cortical regions. These pathological alterations of the central
nervous system are assumed to underly the perception of tinnitus [4–8].
Recent neuromodulation techniques attempt to reverse or modulate these patholog-
ical alterations (for a recent overview, see Langguth et al. [9]). One of these is repetitive
transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation tool with the
capability to evoke neuroplastic changes by a rhythmic administration of brief electromag-
netic pulses [10–12]. By means of low-frequency rTMS, it is possible to inhibit cortical
excitability, whereas high-frequency protocols are assumed to increase cortical excitability.
These statements should be seen as a rule of thumb, as several findings show high inter- and
intra-individual variability of rTMS, with a lot of subjects not behaving accordingly [13–16].
On account of this, temporal 1 Hz rTMS was applied in order to inhibit tinnitus-
associated hyperactivity of the auditory cortex and consequently suppress the tinnitus
percept [17,18].
For many years, various treatment trials deployed left-temporal low-frequency rTMS,
showing greatly varying findings and high inter-individual variability in responses (for
an overview, see Schoisswohl et al. [19]). Given this backdrop, additional studies also
examined the consequences of other rTMS approaches such as multi-site stimulation
protocols [20,21], prefrontal cortex stimulation [22–24] or high-frequency rTMS [25–27], as
well as continuous theta-burst stimulations [25,28,29] as a treatment option for tinnitus.
Nevertheless, its clinical effectiveness is still not obvious. Recent reviews and meta-analyses
conclude that there is no clear indication for an effect [9,30,31], while others report potential
effectiveness for its clinical administration [32,33], especially over the auditory cortex [34].
This lack of evidence may be explained by the fact that there is still a certain ambiguity
concerning the correct rTMS parameters (e.g., frequency or position) for the application in
tinnitus. Admittedly, the effects of non-invasive brain stimulation methods in general are
subject to rigorous intra- and inter-individual variability, conceivably caused by a complex
interplay of technical and physiological parameters [35–38].
A personalization of stimulation protocols might provide a remedy and further en-
hance efficacy. Individualization of magnetic stimulation might be capable of resolving
the issue of effect variability within the same type of pathology. Its implementation in
neuropsychiatric research is highly dependent on phenotypes as well as the identification
of appropriate and valid clinical or physiological outcome measures [39,40]. However,
tinnitus provides the tremendous benefit of direct reactions from the patients’ side by
virtue of changes in tinnitus perception and can therefore function as a kind of role model
in rTMS personalization.
Test sessions (i.e., short stimulations with recording of immediate responses) and an
administration of different protocols offer the opportunity to examine the ability of the
different protocols to suppress tinnitus loudness in an individual. In several studies, it has
been demonstrated that tinnitus loudness can be suppressed by means of a single rTMS
sessions for some minutes [41–45], and that suppression patterns vary among patients [46].
The concept of rTMS personalization in the clinical context of tinnitus was first introduced
by Kreuzer et al. [47]. By means of rTMS test sessions with different types of frequencies
and positions, individualized protocols for brief tinnitus suppression were identified and
further used in the course of a daily treatment. These findings emphasize the feasibility of
rTMS individualization and imply superiority over a standard treatment protocol by means
of a higher number of treatment responders, even if no statistical differences between the
standard and the individualized treatment were detected in this relatively small pilot study.
In another preliminary work from our group, using an e-field guided system, we were
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able to demonstrate reliable tinnitus loudness decreases for certain stimulation parameters
as well as the possibility to individualize rTMS characterized by a consistent and sham-
controlled tinnitus loudness suppression in five out of five individuals [48]. Nonetheless,
behavioral responses are governed by certain limitations, such as their highly subjective
matter and the difficulty to accurately evaluate minor changes in the tinnitus percept in
many cases, which might constitute an additional reason for variability in responses.
It is widely established that tinnitus is accompanied by pathologically altered oscil-
latory brain activity patterns. According to the “Thalamo-cortical Dysrhythmia Model”
(TCD), the assumed mechanism behind these changes is peripheral deafferentation causing
thalamic low-frequency activity, which in turn provokes a boost in neural synchrony and
increased gamma activity in auditory regions of the cortex [49–51]. An expansion of the
TCD model, termed “Synchronization-by-Loss-of-Inhibition-Model” (SLIM), presumes
that an ancillary suppression of neurons relevant for inhibition additionally causes dimin-
ished activity in the alpha frequency range. Moreover, pathological gamma in tinnitus is
prompted by this alpha decrease and the concomitant loss of inhibition [52].
Several neurophysiological investigations using electro- or magneto-encephalographic
measurements revealed decreased activity in the alpha band and increased activity in the
delta and gamma frequency ranges [53–58]. In particular, gamma is suggested to be
closely related to the actual tinnitus perception [57,59,60]. These altered spontaneous brain
activities might provide a potential indicator to examine the effect of rTMS in tinnitus.
TMS-EEG investigations have already demonstrated that rTMS successfully mod-
ulates evoked and ongoing brain activity, with effects exceeding the stimulation offset
(neuroplastic consequences) [61–63]. In the clinical context, TMS-EEG approaches are
already used for several neuropsychiatric conditions, such as schizophrenia, depression
or Alzheimer’s disease, in order to identify and investigate the relevance of neurophys-
iological markers as well as to provide a more profound insight into the neuroplastic
consequences of rTMS [64,65]. In case of tinnitus, a combination of rTMS and EEG might
not only help to improve our understanding of the pathophysiology and altered ongoing
brain activity patterns behind tinnitus, but also shed light on neurophysiological markers
for tinnitus suppression. As of yet, only a handful of studies have investigated the conse-
quences of single rTMS sessions on spontaneous brain activity in tinnitus. Müller et al. [46]
applied different stimulation types (1 Hz, continuous theta burst, intermittent theta burst
and individual alpha frequency rTMS) over the temporal cortex and aimed to detect the
most efficient protocol for transient tinnitus suppression per subject. By using magneten-
cephalography (MEG), they could detect a significant increase of alpha power (8–12 Hz)
in the auditory cortex associated with tinnitus suppression. Due to the absence of clear
effects on a whole-group level, the authors emphasize the relevance of analysis on an
individual subject level to unveil the key mechanisms behind tinnitus suppression. In this
context, especially modulations in the alpha frequency band might provide a potential
marker for future attempts in individualizing rTMS. Schecklmann et al. [66] compared
the neuroplastic consequences of rTMS in tinnitus patients with healthy controls and
observed rTMS-specific modulations almost entirely for the group of tinnitus patients.
A left-temporal 1 Hz stimulation with 200 pulses decreased power spectra in the delta
(2–3.5 Hz) and theta (4–7.5 Hz) frequency ranges, as well as increased beta2 (18.5–21 Hz)
frequency band power over frontal areas in tinnitus patients. Right prefrontal cortex 1 Hz
stimulation reduced beta3 (21.5–30 Hz) and gamma (30.5–44 Hz) band activity in tinnitus
patients in temporal areas. In contrast, the control group exhibited enhanced beta3 and
gamma power. Results emphasize the ability to modulate tinnitus-related ongoing brain ac-
tivity, or rather, to induce neuroplastic changes in tinnitus by rTMS in accordance with the
TCD model. However, on a behavioral level, reliable sham-controlled decreases in tinnitus
loudness were solely present in two out of 20 tinnitus patients (one after right-prefrontal,
one after left-temporal rTMS).
Considering past findings, in particular the ability of certain rTMS protocols to tran-
siently decrease tinnitus loudness plus modulate tinnitus-associated oscillatory brain
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activity, up to now, there is no convincing data on test–retest reliability of the effects of
single-session rTMS. A test–retest design has the potential to yield essential details about
effect-consistency, more specifically, if rTMS produces reliable and valid modulations. Find-
ings may promote decisions in choosing appropriate rTMS protocols for daily treatments.
Due to the overall high variability of non-invasive brain stimulation effects, it is of utmost
importance to identify reliable brain stimulation techniques to cope with this variability.
Hence, one of the objectives of the current experiment was to scrutinize the test–retest
reliability of different rTMS protocols in short-term tinnitus suppression and modifying
resting state EEG activity. For this purpose, the study design used in Schoisswohl et al. [48]
with pre–post-rTMS tinnitus loudness ratings was expanded by electrophysiological mea-
sures before and after each rTMS. Furthermore, it was reduced by the factor stimulation
position since the majority of patients (three out of five) responded to a stimulation over
temporo-parietal regions. An e-field guided stimulation over the left and right temporo-
parietal junction allows for a more precise investigation of the parameter frequency, since
past studies show inconsistent results in this regard.
Beyond that, we wanted to undertake further research on the personalization of rTMS
by means of the model tinnitus. The aim was to assess the feasibility of identifying an
rTMS protocol for consistent and sham-superior brief tinnitus suppression per patient
(behavioral response). In light of previous work from Müller et al. [46], together with
the current prevalent neurophysiological models in tinnitus, we wanted to go one step
beyond and strive for a rTMS personalization based on electrophysiological responses.
The specific objective was to ascertain a protocol per patient, which is able to produce
consistent and sham-superior increases in alpha or decreases in the gamma frequency band
(EEG response), respectively. Based on past research, we hypothesize that for the majority
of subjects, it is feasible to identify a personalized rTMS protocol by means of behavioral
or EEG responses. Additionally, we were interested if an EEG response in the alpha or
gamma band is related to a behavioral response, and vice versa.
2. Materials and Methods
2.1. Participants
N = 22 patients (5 female) with chronic subjective tinnitus, recruited from the Inter-
disciplinary Tinnitus Centre in Regensburg, Germany, participated in this experiment.
Participants had to comply with the following inclusion criteria: age between 18 and
75 years, German-speaking, no or stable treatment with psychoactive drugs, absence of
severe somatic, neurological or psychiatric conditions (e.g., acute psychosis, severe de-
pression, alcohol and/or substance abuse or known brain tumor) and no simultaneous
participation in other tinnitus-related experiments or treatments. Further, participants had
to exhibit no contraindications with respect to TMS (e.g., epilepsy or state after traumatic
brain injuries; cf. [67,68]) as well as magnetic resonance imaging (MRI) (e.g., heart pace-
maker, vascular clamp, implanted insulin pump or severe claustrophobia). Each participant
received detailed clarification about the study aim, procedure and applied methods as
well as potential adverse effects related to TMS, and provided written informed consent
before the study start. The study was approved by the ethics committee of the University
of Regensburg, Germany (ethical approval number: 17-820-101).
2.2. Test Session Procedure
Ahead of the rTMS tests sessions, participants’ hearing thresholds for the frequency
range of 125 Hz to 8 kHz were determined by the use of a clinical audiometer (Madsen
Midimate, 622D; GN Otometrics, Taustrus, Denmark). In addition, structural MRI brain
scans (T1) were undertaken with a MAGNETOM 1.5 Tesla scanner (Siemens, Munich,
Germany) for neuro-navigated rTMS and participants were requested to complete German
versions of the Tinnitus Handicap Inventory (THI; [69,70]), the Tinnitus Sample Case His-
tory Questionnaire (TSCHQ; [71]) and the European School for Interdisciplinary Tinnitus
Research Screening Questionnaire (ESIT-SQ; [72]).
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The actual rTMS test sessions lasted approximately three hours and took place on two
different days, with a maximum inter-session interval of two days, whereby daytime was
always the same (±1 h). Both test session days followed the same procedure. On each day,
subjects were stimulated with four different rTMS protocols over the left temporo-parietal
junction (TPJ) and with the same four protocols over the right TPJ (see Section 2.3 Repetitive
Transcranial Magnetic Stimulation). Thus, a total number of 8 different rTMS protocols
was applied on each test session day. Magnetic stimulation protocols were administered
in a randomized sequence on each day, with the exception that the order of hemisphere
was inverted (if the stimulation sequence on the first day started over the left hemisphere,
it began with a stimulation over the right hemisphere on the second day). During three
minutes before and after each stimulation, patients were requested to focus on their tinnitus
and verbally rate the current loudness of their tinnitus perception on a numeric rating scale
ranging from 0% to 110% at seven different points in time, with an inter-rating interval of
30 s (T0, T30, T60, T90, T120, T150 and T180). The numeric rating scale was anchored at
0% (absence of tinnitus) and at 110% (tinnitus loudness increase of 10%), whereby 100%
corresponds to the patients’ usual perceived tinnitus loudness. Concurrent to these ratings,
resting state oscillatory brain activity was recorded for three minutes each by means of
EEG. For this purpose, participants were instructed to sit calmly, focus on a certain point
in the room and avoid unnecessary eye blinks or muscle movements. Subsequent to each
post-stimulation loudness rating/EEG recording, participants had to evaluate the level of
discomfort caused by the applied rTMS protocol on a numeric rating scale from 0 to 10,
where 10 corresponds to utmost discomfort, or rather intolerability. Figure 1 provides an
illustration of the entire test session proceeding.
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Three different verum rTMS protocols (1, 10, 20 Hz) with 200 pulses each and one sham protocol (0.1 Hz) with 20 pulses
were administered over the left and right temporo-parietal junction in a randomized order. Thus, a total of 8 different rTMS
protocols were applied on each test sessi n day. Before and after each magnetic stimulation, participants were requested to
rate the subjective loudness of their tinnitus n a numeric rating cale fr m 0% o 110% (0%—complete absence of tinnitus;
100%—no change; 110%—10% loudness increase) at seven points in time (30 s inter-rating interval). In parallel to these
ratings, resting state brain activity was recorded with electroencephalography (EEG) for three minutes. At the end of
each rTMS protocol (pre-rating/recording–stimulation–post-rating/recording), patients had to rate the induced level of
discomfort on a numeric rating scale from 0 to 10 (10—utmost discomfort).
2.3. Repetitive Transcranial Magnetic Stimulation (rTMS)
An e-field guided rTMS system (NBT System 2; Nexstim Plc., Helsinki, Finland)
toget er with individual structural MRI scans (T1) was utilized for the test sessions. Prior
to the first session, participants’ resting motor threshold (RMT) was d ter ined accor ing
to th same proce ure as already described in Schoisswo l et al. [48]. Th reby, various
positions over the left primary motor cortex were stimulated until several motor-evoked
potentials (MEP) derived from the thenar muscles of the right hand with a peak-to-peak
amplitude of >50 µV were visible. The stimulation position with the highest MEP amplitude
was repeated via the neuro-navigation system and single pulses with intensity shifts were
applied. The lowest stimulation intensity which produced MEPs with an amplitude of at
least 50 µV in half of the administered pulses was defined as subjects’ RMT. Additionally,
the RMT determination was repeated with a mounted EEG cap using the same motor
hotspot. Magnetic stimulation consisted of 1, 10 and 20 Hz protocols with 200 pulses each
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at 110% RMT, whereas a series of 20 pulses at 0.1 Hz was deployed as an active control
condition (sham) with no assumed neuroplastic consequences [73,74]. Each protocol was
administered over the left and right TPJ, resulting in a total number of eight different rTMS
protocols with approximately six minutes of inter-protocol intervals (3 min of pre- and
post-rTMS EEG recordings; if applicable, there was a waiting period until the subject’s
tinnitus loudness returned to the initial level). An uncooled coil was used for the test
sessions, as the cooled coil produces additional noise, and we aimed at minimizing the
stimulation noise since it could confound both behavioral and neurophysiological effects.
Stimulation positions were localized according to the electrode positions CP5 and CP6
(10–20 System). By virtue of the application of an e-field guided neuro-navigation system
and the opportunity for online visualization of strength and direction of the TMS-induced
e-field on subjects’ anatomical scans, each stimulation was administered with the induced
e-field perpendicular to the sulcus of the brain area of interest. In order to ensure that the
stimulation positions, respectively the induced e-field, remained the same over the two
test sessions, both electrode positions were tagged with a digitization pen and marked on
the individual anatomical images. Next, the coil was placed accordingly, a single pulse
with an intensity of 10% RMT was administered and the corresponding position of the coil
was saved in the neuro-navigation system. With the aid of a system-intern aiming tool, the
exact position of the coil could be repeated with respect to centering, rotation and tilting.
After each protocol, the position was verified and adjusted if necessary. For safety reasons,
all participants were wearing in-ear plugs during the whole stimulation procedure.
2.4. Electroencephalography
2.4.1. Data Acquisition and Preprocessing
Participants’ electrophysiological resting state brain activity was recorded for three
minutes before and after each of the eight rTMS protocols by means of EEG with a
BrainAmp DC system (Brain Products GmbH, Gilching, Germany), in combination with
an Easycap elastic electrode cap (Easycap GmbH, Herrsching, Germany) consisting of
64 electrodes placed according to the 10–20 System (GND: AFz) and the software Brain
Vision Recorder 1.20 (Brain Products GmbH, Germany). EEG measurements were online
referenced to FCz and recorded at a sampling rate of 500 Hz. Impedances were kept lower
than 10 kΩ during the whole recording.
Preprocessing of raw EEG data was conducted with a custom-built pipeline in Matlab
(Matlab R2018b; Mathworks, Natick, MA, USA) by employing functions implemented
in the EEGLAB toolbox [75]. In a first step, EEG data were filtered between 1 and 45 Hz
and segmented into 2 s epochs. Afterwards, the data were visually inspected and single
epochs featuring artifacts or verbal tinnitus loudness ratings were removed from the
signal. For each dataset, the first and last two epochs were rejected as well, and noisy
or deviant sensors were identified for subsequent interpolation. In order to identify and
reject vertical and horizontal eye movements, an independent component analysis (ICA;
fastICA toolbox http://research.ics.aalto.fi/ica/fastica/) was executed. In a next step,
datasets were re-referenced using an average reference and the online reference electrode
FCz was reconstructed and added as a data channel. Previously identified channels with
high signal-to-noise ratio were interpolated using the spherical spline method [76]. As a
last step, preprocessed datasets underwent a final visual inspection.
2.4.2. Power Spectra
Power spectra analysis was performed with the Fieldtrip toolbox [77] in Matlab.
Fast Fourier Transformation (FFT, “mtmfft”) and a hanning window with 1 Hz spectral
smoothing was used for the calculation of pre- and post-stimulation power spectra for each
channel per rTMS protocol. Obtained power spectra underwent a normalization through
a division of the spectral power of every single frequency by the average spectral power
of the whole frequency spectrum. Grand averages were calculated for every pre- and
post-stimulation dataset per channel and the following frequency bands: delta (2–3.5 Hz),
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theta (4–7.5 Hz), alpha (8–12.5 Hz), beta (13–32.5 Hz) and gamma (33–44 Hz) [66,78].
RTMS protocol-specific pre-to-post-power changes in the respective frequency bands were
obtained by subtracting the pre-stimulation from the post-stimulation power for each
channel (∆power = post − pre). Channels Iz, TP9 and TP10, which usually contain noisy
signal, were excluded, resulting in 60 channels for further statistical analysis.
2.5. Statistical Analysis
All subsequent statistical analyses were performed with the statistics software R (R
version 4.0.3; R Foundation for Statistical Analysis, Vienna, Austria) using the packages
“psych” and “ggstatsplot”.
Assumptions for parametric testing were examined with Shapiro–Wilk tests (normal
distribution) and F-Tests (sphericity), and if violated, non-parametric tests were performed.
Significance levels were set to ≤0.05 for all analysis, whereby <0.10 was considered as a
statistical trend. Differences between left and right hearing level, RMT as well as induced
e-field strength with and without mounted EEG cap were analyzed with paired-sample
t-tests and Wilcoxon signed-rank tests, respectively.
2.5.1. Reliability Analysis of TMS-Induced Tinnitus Loudness Changes and
Discomfort Evaluation
Pre-stimulation ratings were averaged (T0–T180) to receive a stable tinnitus loudness
baseline for each protocol per subject. TMS-induced tinnitus loudness changes were
calculated via a subtraction of the mean baseline loudness level from the mean post-
stimulation loudness level (∆loudness = post − baseline). Test–retest reliability of TMS-
induced mean tinnitus suppression as well as discomfort evaluation over both test session
days was analyzed by means of Spearman correlations for each protocol. p-values were
adjusted for multiple comparisons using the Holm–Bonferroni method [79].
2.5.2. Reliability Analysis of TMS-Induced Changes in Oscillatory Brain Activity
Test–retest reliability of protocol-specific pre–post-power spectra changes were an-
alyzed with Spearman correlations. Therefore, the obtained changes were correlated
between the first and second test sessions on a single sensor level per rTMS protocol and
frequency band. Thus, 300 correlations were calculated per rTMS protocol (5 frequency
bands x 60 sensors). Obtained p-values of sensor correlations were adjusted according to the
number of sensors separated per frequency band and protocol using the Holm–Bonferroni
method [79]. In case of significant results, p-values were further corrected for the number of
applied protocols akin to an adjustment for multiple comparisons of behavioral results. We
were exclusively interested in positive correlation outcomes, representing reliability of TMS
effects. Significant positive correlations of channel pairs were identified via correlation
matrices and projected on a 60-channel topographical scalp map, applying color-coding
for received correlation coefficients (rs). A minimum number of two neighboring elec-
trodes featuring significant positive correlations (electrode cluster) was considered as a
reliable TMS-induced change in power spectra. Triangulation of 2D sensors was utilized
for neighboring sensor identification.
2.5.3. rTMS Individualization via Responder Identification Using Behavioral and
Electrophysiological Data
Additional to test–retest reliability analysis, rTMS individualization was examined
based on single-subject responses concerning loudness evaluation and electrophysiological
consequences. Behavioral response to one of the verum interventions was defined as a mean
tinnitus loudness suppression (compare Section 2.5.1 Reliability Analysis of TMS-Induced
Tinnitus Loudness Changes and Discomfort Evaluation) superior to sham stimulation
(∆loudness verum > ∆loudness sham) on both test session days for the same rTMS protocol
and stimulated hemisphere. EEG responders were defined for the alpha (8–12.5 Hz) and
gamma (33–44 Hz) frequency bands separately. In particular, we were interested in alpha
power increases and gamma power decreases from pre- to post-stimulation. As indicated
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in the Introduction Section, alpha increases and gamma decreases are the most valid
biomarkers for tinnitus reductions, as indicated by literature reviews and expert knowledge.
For each subject and protocol, the top 20% of channels exhibiting alpha increases/gamma
decreases were detected and scrutinized with regards to sham-superiority per day.
If a sham-superior alpha increase, respectively gamma decrease, was observed in
the same sensor on both days, plus the corresponding pattern occurred in a minimum
number of two adjacent channels, the subject was designated as either an alpha or gamma
responder. Associations of a behavioral response to any of the eight protocols with an
electrophysiological response in the alpha or gamma frequency band and vice versa were
examined with Fisher’s exact tests due to cell frequencies less than five.
3. Results
3.1. Sample Characteristics
Participants were aged from 43 to 69 years (M = 57.05, SD = 6.79) and had an average
tinnitus duration of 131.64 months (SD = 116.76). The majority reported a bilateral tinnitus
perception as well as loudness fluctuations. No difference in hearing loss between the
left and the right ear was observed, t(13) = −1.36, p = 0.198. THI severity grades ranged
from mild (grade 2) to catastrophic (grade 5) and manifested on average as severe (grade 4)
for the whole sample (M = 58.49, SD = 19.55). As expected, the RMTs were significantly
higher with a mounted EEG cap, p < 0.001. Unexpectedly, the corresponding strength of the
induced e-field was similarly higher, with an EEG-cap t(21) = −6.07, p < 0.001. Although the
motor hotspot for RMT determination was identical, as well as coil centering and rotation,
differences in the e-field might derive from difficulties in the adjustment of coil tilting due
to distances to the scalp, as well as the concomitant stimulation at higher intensities.
Information about participant characteristics can be seen in Table 1.
Table 1. Participant characteristics.
N (female) 22 (5)
Handedness (left/right/both) (4 missing) 0/14/4
Tinnitus laterality (left/right/both/inside head) (4 missing) 1/1/14/2
Tinnitus loudness fluctuation (yes/no) (4 missing) 14/4
M ± SD Md Min Max
Age (years) 57.05 ± 6.79 57.50 43.00 69.00
Tinnitus duration (months) (2 missing) 131.65 ± 116.79 102.00 5.00 420.00
Hearing loss left (dB) (8 missing) 23.42 ± 9.72 22.22 7.22 41.67
Hearing loss right (dB) (8 missing) 27.87 ± 14.29 23.06 7.78 61.88
THI score (0–100) 58.49 ± 19.55 58.00 30.00 90.00
Tinnitus loudness (%) (6 missing) 70.31 ± 19.87 80.00 30.00 90.00
RMT (%) 33.95 ± 5.33 33.00 25.00 46.00
RMT (%) + EEG cap 41.91 ± 9.65 41.00 30.00 66.00
Electrical field (V/m) 54.47 ± 13.90 52.50 27.00 86.00
Electrical field (V/m) + EEG cap 66.66 ± 15.38 66.25 44.00 99.00
M = mean; SD = standard deviation; Md = median; Min = minimum; Max = maximum; THI = Tinnitus Handicap Inventory; RMT = resting
motor threshold; EEG = electroencephalography.
Besides anticipated side effects such as discomfort during rTMS (in particular by rapid
muscle contraction caused by high-frequency protocols) or temporary tinnitus loudness
increases after stimulation, no additional side effects could be observed in the current
sample. Spearman correlations showed significant positive correlations for discomfort
evaluations of each applied rTMS protocol between the two test sessions (see Figure S1 in
the Supplemental Materials).
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3.2. Test–Retest Reliability of TMS-Induced Changes in Tinnitus Loudness and Oscillatory
Brain Activity
No significant correlations were observed for the two test session days with regards
to mean tinnitus loudness changes for any of the protocols (Figure 2). It should be noted
that without considering corrections for multiple comparisons, a significant test–retest
reliability was found for left hemispheric stimulation with 10 Hz and right hemispheric
stimulation with 20 Hz.
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correlations do not withstand a correction for multiple comparison and should therefore not be overrated and interpreted
only exploratively.
On the basis of our predefined reliability criteria, reliable changes in oscillatory brain
activity were solely present for 1 Hz stimulation of the right TPJ, exclusively for the gamma
frequency band. As can be seen from Figure 3, these reliable changes were primarily ob-
served over parieto-occipital regions, whereby neighboring channels PO7 and O1 constitute
a significant reliable cluster. If corrected for multiple comparisons, this effect disappears
and is therefore only conditionally interpretable.
J. Pers. Med. 2021, 11, 536 10 of 19
J. Pers. Med. 2021, 11, x 10 of 20 
 
 
illustrated in Figure 2. Colored ribbons represent confidence intervals (95%). Reliable changes were observed for a (b) 10 
Hz stimulation over the left temporo-parietal junction and a (c) 20 Hz stimulation over the right temporo-parietal junction. 
Both correlations do not withstand a correction for multiple comparison and should therefore not be overrated and inter-
preted only exploratively. 
 
Figure 3. Reliability of TMS-induced changes in oscillatory brain activity. 
Spearman correlations coefficients (rs) of right hemispheric 1 Hz rTMS-induced 
changes in the gamma frequency band (33–44 Hz) for the two test session days are pro-
jected on a topographical map per electrode in Figure 3. Significant reliable electrodes are 
highlighted with asterisks. Separate reliable changes are primarily present over parieto-
occipital electrodes, whereby neighboring channels PO7 and O1 form a significant reliable 
cluster. However, this effect disappears after a correction for multiple comparisons and is 
therefore only conditionally interpretable. 
3.3. rTMS Individualization Using Behavioral and Electrophysiological Data 
In 12 out of 22 (55%) participants, it was possible to identify an individualized rTMS 
protocol for short-term tinnitus suppression characterized by sham-superiority on both 
test session days. From those 12 patients, 10 (83.33%) responded to more than one stimu-
lation type. Detailed information about individual responses together with the induced 
mean tinnitus suppression (averaged over both test session days) can be found in Table 2. 
As presented in Table 3, the majority of subjects responded to a stimulation over the left 
TPJ with 20 Hz (n = 7) and 10 Hz (n = 6), and over the right TPJ with 20 Hz (n = 5). 
Table 2. Individual test session responses per protocol—behavioral and EEG responder. 
Subject Behavioral Responder Alpha (8–12.5 Hz)/Gamma (30.5–44 Hz) 
1 
 1 Hz 10 Hz 20 Hz  1 Hz 10 Hz 20 Hz 
Left 12.86 - - Left - ↓ γ ↑ α ↓ γ 
Right 17.15 - - Right - ↓ γ - 
2 - 
 1 Hz 10 Hz 20 Hz 
Left ↑ α ↓ γ ↑ α ↓ γ - 
Right - - - 
3 
 1 Hz 10 Hz 20 Hz  1 Hz 10 Hz 20 Hz 
Left 3.98 - 3.71 Left ↑ α ↓ γ ↑ α - 
Right - - - Right ↓ γ - - 
Figure 3. Reliability of TMS-induced changes in oscillatory brain activity. Spearman correlations
coefficients (rs) of right hemispheric 1 Hz rTMS-induced changes in the gamma frequency band
(33–44 Hz) for the two test sessio days are projected on a topographical map per electrode in
Figure 3. Significant reliable electrodes are highlighted with asterisks. Separate reliable changes
e primarily present over parieto-occipital electrodes, wh reby neighboring channels PO7 and O1
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3.3. rTMS Individualization Using Behavioral and Electrophysiological Data
In 12 out of 22 (55%) participants, it was possible to identify an individualized rTMS
protocol for short-term tinnitus suppression characterized by sham-superiority on both test
session days. From those 12 patients, 10 (83.33%) responded to more than one stimulation
type. Detailed information about individual responses together with the induced mean
tin itus s ppression (averaged over both test session days) can be found in Table 2. As
presented in Table 3, the majority of subjects responded to a stimulation over the left TPJ
with 20 Hz (n = 7) and 10 Hz (n = 6), and over the right TPJ with 20 Hz (n = 5).
EEG responders were defined by sham-superior alpha power increase or gamma
power decrease in a minimum of two neighboring electrodes in both test sessions. Using
this criterion, 20 alpha responders (90.91%) were identified, showing alpha power increases
for at least one of the six used verum protocols. Left TPJ stimul tion with 10 Hz (n = 10)
or 1 Hz (n = 9), and right TPJ stimulation with 10 Hz (n = 7) produced the most alpha
responders (Table 3). Electrophysiological responses in the gamma band were present in
each investigated subject (100%) for at least one protocol. Subjects responded mainly to
left TPJ stimulation with 10 Hz (n = 13) or 1 Hz (n = 10) and right TPJ stimulation with
10 Hz (n = 8) or 1 Hz (n = 8) (Table 2). Interestingly, 75% of alpha and gamma responders
showed consistent power increases/decreases for more th n one protocol. Table 3 presents
an overview of alpha increases and gamma decreases per rTMS protocol on a single
subject level. Fisher’s exact tests showed no significant association neither for behavioral
responders with alpha or gamma responders nor the other way around.
Electrodes featuring sham-superior alpha/gamma modifications on both days are
presented in Figures 4 and 5 by means of topographical maps displaying the quantity
of electrodes within alpha and gamma responders per rTMS protocol. It is apparent
from Figure 4 that alpha responses primarily appeared in parieto-occipital regions on
both hemispheres, whereas responses in the gamma range were especially present over
frontal regions bilaterally and to some extent over parieto-occipital parts, as outlined in
Figure 5. Detailed electrode information per subject and rTMS protocol can be found in the
Supplementary Materials for alpha (Table S1) and gamma responders (Table S2).
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Table 2. Individual test session responses per protocol—behavioral and EEG responder.
Subject Behavioral Responder Alpha (8–12.5 Hz)/Gamma (30.5–44 Hz)
1
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left 12.86 - - Left - ↓γ ↑α ↓γ
Right 17.15 - - Right - ↓γ -
2 -
1 Hz 10 Hz 20 Hz
Left ↑α ↓γ ↑α ↓γ -
Right - - -
3
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left 3.98 - 3.71 Left ↑α ↓γ ↑α -
Right - - - Right ↓γ - -
4
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - 10.35 - Left ↑α ↓γ - -
Right - 9.28 25.71 Right - - -
5
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - 16.42 - Left ↑α ↓γ ↑α
Right 10 16.79 21.42 Right - - -
6
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - 10.71 - Left ↑α - ↑α
Right - - - Right - ↑α ↓γ -
7 -
1 Hz 10 Hz 20 Hz
Left - ↑α -
Right - ↑α ↑α ↓γ
8
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - 6.07 8.93 Left - ↑α ↓γ ↓γ
Right - 4.64 9.28 Right - ↑α -
9
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - - 3.93 Left ↑α ↓γ ↑α ↓γ ↑α ↓γ
Right 7.55 - - Right ↓γ - -
10
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left 15.36 - 5.71 Left ↓γ ↑α ↓γ
Right - - - Right - ↓γ ↑α ↓γ
11 -
1 Hz 10 Hz 20 Hz
Left ↑α - -
Right ↓γ ↑α ↓γ ↑α
12 -
1 Hz 10 Hz 20 Hz
Left - - -
Right - ↑α ↓γ
13 -
1 Hz 10 Hz 20 Hz
Left ↓γ ↑α ↓γ -
Right ↑α ↓γ ↓γ -
14 -
1 Hz 10 Hz 20 Hz
Left ↑α ↓γ ↑α ↓γ
Right ↓γ - ↑α
15 -
1 Hz 10 Hz 20 Hz
Left ↓γ ↑α -
Right ↓γ - -
16
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - 5 12.85 Left - ↑α ↓γ -
Right - - 10 Right - ↑α ↓γ
17 -
1 Hz 10 Hz 20 Hz
Left - ↓γ -
Right ↑α ↓γ ↑α ↓γ
18 -
1 Hz 10 Hz 20 Hz
Left ↓γ ↓γ ↑α ↓γ
Right ↑α ↓γ ↑α -
19
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - 13.57 13.57 Left ↑α ↓γ -
Right - - - Right ↑α ↓γ ↑α
20 -
1 Hz 10 Hz 20 Hz
Left ↓γ ↓γ -
Right - - -
21
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - - - Left - - ↓γ
Right 7.14 - 3.93 Right ↓γ ↓γ ↓γ
22
1 Hz 10 Hz 20 Hz 1 Hz 10 Hz 20 Hz
Left - - 7.85 Left ↓γ ↑α ↓γ -
Right - - - Right - - -
Note: Behavioral response was defined via a sham-superior tinnitus suppression on both test session days in at least one of the verum
protocols. EEG response was defined as sham-superior alpha increases, respectively gamma decreases, in a minimum number of two
neighboring electrodes on both test session days in at least one verum protocol. For behavioral responders, the mean tinnitus suppression
(averaged over both test session days) is presented per rTMS protocol. Alpha increases (↑ α) and gamma decreases (↓ γ) are equally
presented per subject and protocol. Dashes indicate no response.
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Table 3. Summary of behavioral and electrophysiological responder per rTMS protocol.
Behavioral Responder ↑ Alpha ↓ Gamma
Total number of responders (N) 12 20 22
Number of responders per protocol (N)
Left 1 Hz 3 9 10
Right 1 Hz 4 4 8
Left 10 Hz 6 10 13
Right 10 Hz 3 7 8
Left 20 Hz 7 6 7
Right 20 Hz 5 6 6
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showing sham-superior increases in the alpha frequency band in a minimum number of two neighboring channels on 
both test session days are illustrated per rTMS protocol. Responses in the alpha frequency band (8–12.5 Hz) to one of the 
verum protocols primarily occurred over parieto-occipital electrodes. 
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4. Discussion
The g als of this experiment were to ascertain whether it is possible to identify
treatment protocols that provide reliable effects both on t e behavioral and on the electro-
physiological level, as this is a precondition for individualizing treatme t. We performed
two test sessions, at which six active and two sham protocols were administered. We
evaluated reliability by comparing tinnitus suppression effects and electrophysiological
effects on an individual level by responder identification. Moreover, we performed whole-
group analysis, in which we correlated the behavioral and electrophysiological effects of
all stimulation protocols between both test sessions.
The main finding of our study was that in 55% of patients, we could identify a
stimulation protocol that reduced tinnitus loudness transiently in both sessions, reliably
more than sham stimulation. When we defined response by the effects on oscillatory brain
activity, the number was even higher, with 20 out of 22 patients in which a specific rTMS
protocol increased alpha more than sham, and with 22 out of 22 in which a specific rTMS
protocol decreased gamma more than sham. These observations are in accordance with our
a priori assumptions of rTMS personalization in the majority of subjects as well as findings
from previous studies.
Correlation analysis for the whole group revealed reliable changes in tinnitus loudness
after left TPJ stimulation with 10 Hz and right TPJ stimulation with 20 Hz. With respect to
modulatory effects of rTMS on oscillatory brain activity, reliable changes could be obtained
after right TPJ stimulation with 1 Hz in the gamma frequency band over parieto-occipital
regions. However, these findings do not withstand a correction for multiple comparison
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and should therefore not be overrated and interpreted only exploratively. Nevertheless,
the observed effect of rTMS on gamma activity fits well with a previous TMS-EEG study,
where right frontal 1 Hz rTMS decreased gamma band activity over right temporal regions
in tinnitus patients, whereas it increased gamma activity in healthy controls [66]. Gamma
activity is supposed to be strongly connected with tinnitus perception [57,59,60]. However,
as mentioned above, the effects of the first and the second session were not significantly
correlated when statistical corrections for multiple comparisons were performed.
Taking our findings together, we can conclude that it is possible to identify responders
for specific rTMS protocols, who demonstrate a reliable behavioral or electrophysiologic
response on a specific rTMS protocol. However, if we investigate the effects of a given
protocol for the whole sample, the variability of the effect is relatively large from session
to session.
Presumably, the effects depend on the brain state before or during rTMS [80], and this
brain state might vary from session to session. In the current study, the experimental design
with six active and two sham protocols per session might have increased this variability, as
after-effects from preceding protocols cannot be excluded as confounding factors.
The limited test–retest reliability corroborates the claim that effects of rTMS in gen-
eral [37,38,81–83] but also treatment effects in tinnitus [9,84] are subject to high variability.
Thus, it is most likely that single-subject impacts simply do not transfer to statistical analysis
on a group level, highlighting the need and importance of personalized rTMS approaches.
On the other hand, it has been demonstrated that patients who benefit once from
rTMS have a high chance to benefit from repeated rTMS treatment [85,86].
This clinical observation fits with our finding to identify treatment responders to
specific rTMS protocols.
Our results also corroborate findings from several previous studies in which the feasi-
bility of a customization of rTMS for tinnitus via test sessions has been demonstrated [47,48].
The responder rate of 55% in our study (12 out of 22) is in a similar range as in two previous
studies (Kreuzer et al., 50% responder [47], and Schoisswohl et al., 100% responder [48]).
However, both studies deployed magnetic stimulations over either prefrontal cortical
regions or different positions over the superior temporal gyrus, whereas the current study
targeted only a single region of the temporal cortex. The present goal was to examine
the parameter frequency in more detail. Interestingly, the vast majority of participants re-
sponded to high-frequency stimulations over the left TPJ. It is assumed that high-frequency
protocols produce increases of cortical excitability [15]. Consequently, high-frequency
rTMS is most likely not able to reduce tinnitus-associated temporal hyperactivity. However,
it has been suggested that the induced effects can vary or shift across different targets
of the cortex [43] and are dependent on the intrinsic state of the brain region prior to
stimulation [80,87–89]. Based on this, it could be the case that pathological auditory cortex
hyperactivity as an intrinsic state of the “tinnitus brain” might cause a reversal of sup-
posed high-frequency effects (shift from excitatory to inhibitory). In accordance with the
present results, previous studies have demonstrated responder rates between 40% and
57% in single-session experiments with high-frequency stimulation protocols [41,42,45,90].
Likewise, treatment studies with high-frequency rTMS over the temporo-parietal cortex
were able to show significant reductions in tinnitus distress [26,27].
In addition to an rTMS individualization based on behavioral responses, the current
investigation has striven for a novel attempt in rTMS individualization with objective
measures. By the use of TMS-EEG combinatory measurements, we wanted to overcome the
limitations of subjective tinnitus loudness ratings and identify personalized rTMS protocols
via sham-superior increases in alpha, respectively decreases in gamma, frequency band
power in at least two neighboring EEG electrodes in both test sessions. The utilization of
especially these frequency bands as an electrophysiological response indicator is based
on current neurophysiological models. In tinnitus, pathological diminished alpha band
activity was observed in contrast to healthy controls [57,58], whereby during states of brief
tinnitus suppression either after sound stimulation [91] or after rTMS [46], increases in
J. Pers. Med. 2021, 11, 536 15 of 19
alpha power were detected, while gamma band activity is assumed to underly the actual
tinnitus perception [57,59] by associations with tinnitus loudness [54,60]. Interestingly, we
were able to identify a substantially higher number of EEG responders than behavioral
responders. For a total number of 20 participants, it was possible to detect an alpha
response for at least one rTMS protocol, whereas the entire sample featured responses
in the gamma frequency band. It is noteworthy that the quantity of alpha or gamma
responders was almost twice as much as for behavioral responders. In line with our
behavioral observations, a left 10 Hz stimulation resulted in the highest quantity of alpha
and gamma responders. It has been shown that this type of stimulation can modulate
alpha oscillations [92] and that alpha and gamma oscillations show a strong interplay not
only in tinnitus [52,93].
Since neurophysiological investigations were able to demonstrate relationships of the
alpha and gamma band with tinnitus loudness [46,54,60,91], we addressed the question of
whether a response in the alpha or gamma band is associated with a behavioral response,
and vice versa. Our analysis did not reveal any relationship of EEG and behavioral
responders, hampering the interpretability of our alpha and gamma findings as relevant for
tinnitus loudness decreases in the current sample. A potential explanation for this lack of
association could derive from the possibility that rTMS-specific modulations/neuroplastic
consequences as measured with EEG simply do not instantly translate into behavioral
responses. Consequently, longer periods of stimulation with an individualized rTMS
protocol based on patients’ EEG response (protocol with strongest alpha increase/gamma
decrease), for example within the course of a daily treatment, might accumulate over time
into behavioral effects and could tackle the deficiency of effectiveness in current rTMS
treatment trials for tinnitus.
Future studies should strive for a systematic implementation of test session approaches
and investigate the therapeutic consequences of personalized rTMS in more detail. The
present experiment underscores the feasibility of rTMS individualization via behavioral
or electrophysiological responses. The results and methodology described in this sample
of tinnitus patients might encourage neuromodulation attempts in other pathologies to
personalize rTMS in order to account for inter-subject variability in rTMS response.
5. Conclusions
The aim of this investigation was to examine the feasibility of rTMS individualization
in tinnitus. This involved the identification of responders to specific rTMS protocols and
the assessment of test–retest reliability of rTMS effects in tinnitus suppression and ongoing
brain activity. We were able to demonstrate the feasibility of rTMS individualization by
using test sessions with different rTMS protocols. Responses to specific protocols based on
electrophysiological signatures could be identified in all patients, and responses based on
behavioral effects in the majority of patients. In contrast, test–retest reliability, as assessed
with correlation analyses for the various rTMS protocols, was rather low both for behavioral
and electrophysiological effects.
Taken together, these findings are highly encouraging for efforts to enhance the efficacy
of rTMS by personalizing stimulation protocols.
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